DILI: New Insights into Diagnosis and Management
- PMID: 23730228
- PMCID: PMC3666953
- DOI: 10.1007/s11901-012-0159-x
DILI: New Insights into Diagnosis and Management
Abstract
Drug-induced liver injury continues to have a significant impact. With over 1000 drugs now registered as causing DILI, this form of liver injury is the most cited reason for withdrawal of a drug from the marketplace. Despite this, the diagnosis of DILI continues to rely on subjective measures and expert opinion with results that are both difficult to verify and reproduce. However, recent developments in DILI research may provide new insights to improve diagnosis and treatment in the future.
Keywords: acetaminophen; biotransformation; genetic polymorphism; genome wide association study; herbal and dietary supplements.
References
-
- Ostapowicz G, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med. 2002;137(12):947–54. - PubMed
-
- Navarro VJ, Senior JR. Drug-related hepatotoxicity. N Engl J Med. 2006;354(7):731–9. - PubMed
-
- Lee WM. Drug-induced hepatotoxicity. N Engl J Med. 2003;349(5):474–85. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources